 | • レポートコード：GIR-105X09828 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ヤヌスキナーゼ（JAK）阻害剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ヤヌスキナーゼ（JAK）阻害剤の種類別市場規模（自己免疫疾患、腫瘍）、用途別市場規模（クリニック、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ヤヌスキナーゼ（JAK）阻害剤の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Astellas Pharma, Inc.、Eli Lilly and Co.、Incyte Corp.、Novartis AG、Pfizer Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：自己免疫疾患、腫瘍 ・用途別分析2016年-2026年：クリニック、病院 ・ヤヌスキナーゼ（JAK）阻害剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ヤヌスキナーゼ（JAK）阻害剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ヤヌスキナーゼ（JAK）阻害剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ヤヌスキナーゼ（JAK）阻害剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ヤヌスキナーゼ（JAK）阻害剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Janus Kinase (JAK) Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Janus Kinase (JAK) Inhibitors size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Janus Kinase (JAK) Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Janus Kinase (JAK) Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Autoimmune disorders
Oncology
Market segment by Application can be divided into
Clinics
Hospitals
The key market players for global Janus Kinase (JAK) Inhibitors market are listed below:
Astellas Pharma, Inc.
Eli Lilly and Co.
Incyte Corp.
Novartis AG
Pfizer Inc.
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Janus Kinase (JAK) Inhibitors Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Janus Kinase (JAK) Inhibitors Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Autoimmune disorders
1.2.3 Oncology
1.3 Market Analysis by Application
1.3.1 Overview: Global Janus Kinase (JAK) Inhibitors Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinics
1.3.3 Hospitals
1.4 Global Janus Kinase (JAK) Inhibitors Market Size & Forecast
1.4.1 Global Janus Kinase (JAK) Inhibitors Sales in Value (2016-2026))
1.4.2 Global Janus Kinase (JAK) Inhibitors Sales in Volume (2016-2026)
1.4.3 Global Janus Kinase (JAK) Inhibitors Price by Type (2016-2026) & (USD/Unit)
1.5 Global Janus Kinase (JAK) Inhibitors Production Capacity Analysis
1.5.1 Global Janus Kinase (JAK) Inhibitors Total Production Capacity (2016-2026)
1.5.2 Global Janus Kinase (JAK) Inhibitors Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Janus Kinase (JAK) Inhibitors Market Drivers
1.6.2 Janus Kinase (JAK) Inhibitors Market Restraints
1.6.3 Janus Kinase (JAK) Inhibitors Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma, Inc.
2.1.1 Astellas Pharma, Inc. Details
2.1.2 Astellas Pharma, Inc. Major Business
2.1.3 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Product and Services
2.1.4 Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Eli Lilly and Co.
2.2.1 Eli Lilly and Co. Details
2.2.2 Eli Lilly and Co. Major Business
2.2.3 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Product and Services
2.2.4 Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Incyte Corp.
2.3.1 Incyte Corp. Details
2.3.2 Incyte Corp. Major Business
2.3.3 Incyte Corp. Janus Kinase (JAK) Inhibitors Product and Services
2.3.4 Incyte Corp. Janus Kinase (JAK) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Janus Kinase (JAK) Inhibitors Product and Services
2.4.4 Novartis AG Janus Kinase (JAK) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Pfizer Inc.
2.5.1 Pfizer Inc. Details
2.5.2 Pfizer Inc. Major Business
2.5.3 Pfizer Inc. Janus Kinase (JAK) Inhibitors Product and Services
2.5.4 Pfizer Inc. Janus Kinase (JAK) Inhibitors Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Janus Kinase (JAK) Inhibitors Sales by Manufacturer
3.1 Global Janus Kinase (JAK) Inhibitors Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Janus Kinase (JAK) Inhibitors Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Janus Kinase (JAK) Inhibitors
3.4 Market Concentration Rate
3.4.1 Top 3 Janus Kinase (JAK) Inhibitors Manufacturer Market Share
3.4.2 Top 6 Janus Kinase (JAK) Inhibitors Manufacturer Market Share
3.5 Global Janus Kinase (JAK) Inhibitors Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Janus Kinase (JAK) Inhibitors Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Janus Kinase (JAK) Inhibitors Market Size by Region
4.1.1 Global Janus Kinase (JAK) Inhibitors Sales in Volume by Region (2016-2026)
4.1.2 Global Janus Kinase (JAK) Inhibitors Revenue by Region (2016-2026)
4.2 North America Janus Kinase (JAK) Inhibitors Revenue (2016-2026)
4.3 Europe Janus Kinase (JAK) Inhibitors Revenue (2016-2026)
4.4 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue (2016-2026)
4.5 South America Janus Kinase (JAK) Inhibitors Revenue (2016-2026)
4.6 Middle East and Africa Janus Kinase (JAK) Inhibitors Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Janus Kinase (JAK) Inhibitors Sales in Volume by Type (2016-2026)
5.2 Global Janus Kinase (JAK) Inhibitors Revenue by Type (2016-2026)
5.3 Global Janus Kinase (JAK) Inhibitors Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Janus Kinase (JAK) Inhibitors Sales in Volume by Application (2016-2026)
6.2 Global Janus Kinase (JAK) Inhibitors Revenue by Application (2016-2026)
6.3 Global Janus Kinase (JAK) Inhibitors Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Janus Kinase (JAK) Inhibitors Sales by Type (2016-2026)
7.2 North America Janus Kinase (JAK) Inhibitors Sales by Application (2016-2026)
7.3 North America Janus Kinase (JAK) Inhibitors Market Size by Country
7.3.1 North America Janus Kinase (JAK) Inhibitors Sales in Volume by Country (2016-2026)
7.3.2 North America Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Janus Kinase (JAK) Inhibitors Sales by Type (2016-2026)
8.2 Europe Janus Kinase (JAK) Inhibitors Sales by Application (2016-2026)
8.3 Europe Janus Kinase (JAK) Inhibitors Market Size by Country
8.3.1 Europe Janus Kinase (JAK) Inhibitors Sales in Volume by Country (2016-2026)
8.3.2 Europe Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Type (2016-2026)
9.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Application (2016-2026)
9.3 Asia-Pacific Janus Kinase (JAK) Inhibitors Market Size by Region
9.3.1 Asia-Pacific Janus Kinase (JAK) Inhibitors Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Janus Kinase (JAK) Inhibitors Sales by Type (2016-2026)
10.2 South America Janus Kinase (JAK) Inhibitors Sales by Application (2016-2026)
10.3 South America Janus Kinase (JAK) Inhibitors Market Size by Country
10.3.1 South America Janus Kinase (JAK) Inhibitors Sales in Volume by Country (2016-2026)
10.3.2 South America Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Type (2016-2026)
11.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Application (2016-2026)
11.3 Middle East & Africa Janus Kinase (JAK) Inhibitors Market Size by Country
11.3.1 Middle East & Africa Janus Kinase (JAK) Inhibitors Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Janus Kinase (JAK) Inhibitors Typical Distributors
12.3 Janus Kinase (JAK) Inhibitors Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Janus Kinase (JAK) Inhibitors Revenue by Type, (USD Million), 2021-2026
Table 2. Global Janus Kinase (JAK) Inhibitors Revenue by Application, (USD Million), 2021-2026
Table 3. Astellas Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Pharma, Inc. Major Business
Table 5. Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Product and Services
Table 6. Astellas Pharma, Inc. Janus Kinase (JAK) Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Eli Lilly and Co. Basic Information, Manufacturing Base and Competitors
Table 8. Eli Lilly and Co. Major Business
Table 9. Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Product and Services
Table 10. Eli Lilly and Co. Janus Kinase (JAK) Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Incyte Corp. Basic Information, Manufacturing Base and Competitors
Table 12. Incyte Corp. Major Business
Table 13. Incyte Corp. Janus Kinase (JAK) Inhibitors Product and Services
Table 14. Incyte Corp. Janus Kinase (JAK) Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Janus Kinase (JAK) Inhibitors Product and Services
Table 18. Novartis AG Janus Kinase (JAK) Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Inc. Major Business
Table 21. Pfizer Inc. Janus Kinase (JAK) Inhibitors Product and Services
Table 22. Pfizer Inc. Janus Kinase (JAK) Inhibitors Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Global Janus Kinase (JAK) Inhibitors Sales by Manufacturer (2019-2021e) & (K Units)
Table 24. Global Janus Kinase (JAK) Inhibitors Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 25. Market Position of Manufacturers in Janus Kinase (JAK) Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 26. Global Janus Kinase (JAK) Inhibitors Production Capacity by Company, (K Units): 2020 VS 2021
Table 27. Head Office and Janus Kinase (JAK) Inhibitors Production Site of Key Manufacturer
Table 28. Global Janus Kinase (JAK) Inhibitors Sales by Region (2016-2021e) & (K Units)
Table 29. Global Janus Kinase (JAK) Inhibitors Sales by Region (2021-2026) & (K Units)
Table 30. Global Janus Kinase (JAK) Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 31. Global Janus Kinase (JAK) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 32. Global Janus Kinase (JAK) Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 33. Global Janus Kinase (JAK) Inhibitors Sales by Type (2021-2026) & (K Units)
Table 34. Global Janus Kinase (JAK) Inhibitors Revenue by Type (2016-2021e) & (USD Million)
Table 35. Global Janus Kinase (JAK) Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 36. Global Janus Kinase (JAK) Inhibitors Price by Type (2016-2021e) & (USD/Unit)
Table 37. Global Janus Kinase (JAK) Inhibitors Price by Type (2021-2026) & (USD/Unit)
Table 38. Global Janus Kinase (JAK) Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 39. Global Janus Kinase (JAK) Inhibitors Sales by Application (2021-2026) & (K Units)
Table 40. Global Janus Kinase (JAK) Inhibitors Revenue by Application (2016-2021e) & (USD Million)
Table 41. Global Janus Kinase (JAK) Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 42. Global Janus Kinase (JAK) Inhibitors Price by Application (2016-2021e) & (USD/Unit)
Table 43. Global Janus Kinase (JAK) Inhibitors Price by Application (2021-2026) & (USD/Unit)
Table 44. North America Janus Kinase (JAK) Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 45. North America Janus Kinase (JAK) Inhibitors Sales by Country (2021-2026) & (K Units)
Table 46. North America Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 47. North America Janus Kinase (JAK) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 48. North America Janus Kinase (JAK) Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 49. North America Janus Kinase (JAK) Inhibitors Sales by Type (2021-2026) & (K Units)
Table 50. North America Janus Kinase (JAK) Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 51. North America Janus Kinase (JAK) Inhibitors Sales by Application (2021-2026) & (K Units)
Table 52. Europe Janus Kinase (JAK) Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 53. Europe Janus Kinase (JAK) Inhibitors Sales by Country (2021-2026) & (K Units)
Table 54. Europe Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 55. Europe Janus Kinase (JAK) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 56. Europe Janus Kinase (JAK) Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 57. Europe Janus Kinase (JAK) Inhibitors Sales by Type (2021-2026) & (K Units)
Table 58. Europe Janus Kinase (JAK) Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 59. Europe Janus Kinase (JAK) Inhibitors Sales by Application (2021-2026) & (K Units)
Table 60. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Region (2016-2021e) & (K Units)
Table 61. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Region (2021-2026) & (K Units)
Table 62. Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Region (2016-2021e) & (USD Million)
Table 63. Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 64. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 65. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Type (2021-2026) & (K Units)
Table 66. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 67. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales by Application (2021-2026) & (K Units)
Table 68. South America Janus Kinase (JAK) Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 69. South America Janus Kinase (JAK) Inhibitors Sales by Country (2021-2026) & (K Units)
Table 70. South America Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 71. South America Janus Kinase (JAK) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 72. South America Janus Kinase (JAK) Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 73. South America Janus Kinase (JAK) Inhibitors Sales by Type (2021-2026) & (K Units)
Table 74. South America Janus Kinase (JAK) Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 75. South America Janus Kinase (JAK) Inhibitors Sales by Application (2021-2026) & (K Units)
Table 76. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Country (2016-2021e) & (K Units)
Table 77. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Country (2021-2026) & (K Units)
Table 78. Middle East & Africa Janus Kinase (JAK) Inhibitors Revenue by Country (2016-2021e) & (USD Million)
Table 79. Middle East & Africa Janus Kinase (JAK) Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 80. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Type (2016-2021e) & (K Units)
Table 81. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Type (2021-2026) & (K Units)
Table 82. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Application (2016-2021e) & (K Units)
Table 83. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales by Application (2021-2026) & (K Units)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Janus Kinase (JAK) Inhibitors Typical Distributors
Table 87. Janus Kinase (JAK) Inhibitors Typical Customers
List of Figures
Figure 1. Janus Kinase (JAK) Inhibitors Picture
Figure 2. Global Janus Kinase (JAK) Inhibitors Sales Market Share by Type in 2020
Figure 3. Autoimmune disorders
Figure 4. Oncology
Figure 5. Global Janus Kinase (JAK) Inhibitors Sales Market Share by Application in 2020
Figure 6. Clinics
Figure 7. Hospitals
Figure 8. Global Janus Kinase (JAK) Inhibitors Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 9. Global Janus Kinase (JAK) Inhibitors Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Janus Kinase (JAK) Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Janus Kinase (JAK) Inhibitors Sales (2016-2026) & (K Units)
Figure 30. Global Janus Kinase (JAK) Inhibitors Production Capacity (2016-2026) & (K Units)
Figure 31. Global Janus Kinase (JAK) Inhibitors Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Janus Kinase (JAK) Inhibitors Market Drivers
Figure 33. Janus Kinase (JAK) Inhibitors Market Restraints
Figure 34. Janus Kinase (JAK) Inhibitors Market Trends
Figure 35. Global Janus Kinase (JAK) Inhibitors Sales Market Share by Manufacturer in 2020
Figure 36. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Manufacturer in 2020
Figure 37. Janus Kinase (JAK) Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Janus Kinase (JAK) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Janus Kinase (JAK) Inhibitors Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Janus Kinase (JAK) Inhibitors Sales Market Share by Region (2016-2026)
Figure 41. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 42. North America Janus Kinase (JAK) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 43. Europe Janus Kinase (JAK) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 45. South America Janus Kinase (JAK) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Janus Kinase (JAK) Inhibitors Revenue (2016-2026) & (USD Million)
Figure 47. Global Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2016-2026)
Figure 48. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Type (2016-2026)
Figure 49. Global Janus Kinase (JAK) Inhibitors Price by Type (2016-2026) & (USD/Unit)
Figure 50. Global Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2016-2026)
Figure 51. Global Janus Kinase (JAK) Inhibitors Revenue Market Share by Application (2016-2026)
Figure 52. Global Janus Kinase (JAK) Inhibitors Price by Application (2016-2026) & (USD/Unit)
Figure 53. North America Janus Kinase (JAK) Inhibitors Sales Market Share by Country (2016-2026)
Figure 54. North America Janus Kinase (JAK) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 55. North America Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2016-2026)
Figure 56. North America Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2016-2026)
Figure 57. Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Country (2016-2026)
Figure 58. Europe Janus Kinase (JAK) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 59. Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2016-2026)
Figure 60. Europe Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Janus Kinase (JAK) Inhibitors Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2016-2026)
Figure 65. South America Janus Kinase (JAK) Inhibitors Sales Market Share by Country (2016-2026)
Figure 66. South America Janus Kinase (JAK) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 67. South America Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2016-2026)
Figure 68. South America Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Janus Kinase (JAK) Inhibitors Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Janus Kinase (JAK) Inhibitors Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のBRAFキナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The BRAF Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…- 世界の未分化リンパ腫キナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The Anaplastic Lymphoma Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- チロシンキナーゼJAK阻害剤の世界市場2018-2025 This study researches the market size of Tyrosine Kinase JAK Inhibitors, presents the global Tyrosine Kinase JAK Inhibitors sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.This report focuses on the key data information of…
- チロシンキナーゼ阻害剤の世界市場2018-2025 Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface.The global tyrosine kinase inhibitors market is expanding owing to high prevalence and increase in incidence of cancer across the globe. In 2018, the global Tyrosine Kinase In…
- Rho関連タンパク質キナーゼの世界市場2018-2025 In 2018, the global Rho Associated Protein Kinase market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Rho Associated Protein…